- Marketwired•2 days ago
Cannabis Science Selects Influential Southern California Financial Firm as the Lead to Raise the Proposed 25 Million USD in Expansion Capital and Boost its Industry Footprint
Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce that it has selected an influential Southern California Financial Firm as the ...
- Marketwired•4 days ago
Cannabis Science 2017 Black Tie Gala for Cannabinoid Research Targeting Critical Ailments, Testimonials, Celebrity Interests, New Partnerships, and Loyalty Gift to Shareholders
Cannabis Science, Inc. , a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce updates to its 2017 Gala. The venue has been narrowed down to a short list ...
- Marketwired•7 days ago
Cannabis Science Continues Expansions as it Negotiates to Acquire Two Medical Marijuana Dispensaries in Los Angeles, California; The Company Expects to Sign Closing Documents Shortly
Cannabis Science, Inc. , a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that its expansions plans are well underway as it negotiates to purchase two ...
CBIS : Summary for CANNABIS SCIENCE INC - Yahoo Finance
Cannabis Science, Inc. (CBIS)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.07 - 0.08|
|52 Week Range||0.01 - 0.14|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-14.80|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|